Tirzepatide, developed by Eli Lilly, targets both GLP-1 and GIP receptorsthe latter being glucose-dependent insulinotropic polypeptide, another hormone tied to insulin sensitivity and fat metabolism
Both belong to the class of incretin-based therapies , but they target the gut hormone pathways in different ways
In clinical wasting conditions, geriatric hyponutrition, post-surgical recovery requiring caloric surplus, and mass-building phases where getting sufficient calories is genuinely difficult, the orexigenic effect of GHRP-6 is not a side effect
Per VetOne's website each mL of liquid contains: Cyanocobalamin (Vitamin B-12) 1000mcg, sodium chloride, ammonium sulfate, citric acid, sodium citrate, and benzyl alcohol (preservative)
doi: 10.1016/j.bbadis.2017.03.003